Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
View all comments(0)
April 17 (Reuters) - Vincerx Pharma Inc VINC.O:
VINCERX PHARMA, INC. ANNOUNCES INTENT TO DELIST FROM NASDAQ AND DEREGISTER WITH THE SEC
VINCERX PHARMA INC - STOCK TO RESUME TRADING ON APRIL 21, 2025
VINCERX PHARMA INC - STOCK TO BE PERMANENTLY SUSPENDED ON APRIL 23, 2025
VINCERX PHARMA INC - BOARD DECIDES TO DISSOLVE, LIQUIDATE, AND WIND-UP BUSINESS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Tradingkey








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.